Last reviewed · How we verify

Progesterone Lozenges

Beth Israel Deaconess Medical Center · Phase 3 active Biologic

Progesterone acts as a steroid hormone that binds to progesterone receptors to modulate reproductive and metabolic processes.

Progesterone acts as a steroid hormone that binds to progesterone receptors to modulate reproductive and metabolic processes. Used for Progesterone supplementation in pregnancy (likely indication given phase 3 status), Menstrual cycle regulation or hormone replacement therapy (potential indication).

At a glance

Generic nameProgesterone Lozenges
SponsorBeth Israel Deaconess Medical Center
Drug classSteroid hormone
TargetProgesterone receptor (PR)
ModalityBiologic
Therapeutic areaReproductive Health / Endocrinology
PhasePhase 3

Mechanism of action

Progesterone is a naturally occurring steroid hormone that exerts its effects by binding to intracellular progesterone receptors (PR-A and PR-B), which function as ligand-activated transcription factors. The lozenge formulation allows for buccal/oral mucosal absorption, potentially providing more direct systemic delivery compared to other routes. This mechanism supports progesterone's role in maintaining pregnancy, regulating menstrual cycles, and modulating endometrial and breast tissue.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: